This case study analyzes a 70-year-old female patient, M.W., diagnosed with mild Alzheimer's dementia based on her symptoms of memory loss and an MMSE score of 22. The analysis includes a review of her current medications (Fosinopril, Metoprolol, Warfarin, Vitamin D, and Acetaminophen) and proposes an updated drug therapy plan including Galantamine hydrobromide. The therapeutic plan focuses on slowing cognitive impairment, managing behavioral symptoms, and enhancing daily function. The case study also outlines medical tests, including neurological exams, brain imaging, and genetic testing, along with lifestyle changes to support the patient's mental and physical health. Follow-up care recommendations and potential adverse reactions are discussed, emphasizing the need for regular monitoring and patient education to improve the efficacy of treatment. The study concludes with a summary of the disease, early interventions, and the importance of pharmacological interventions and lifestyle adjustments to improve symptoms.